stocking stuffer stocks

5 Stocking Stuffer Stocks for Christmas 2022

The end of the year is often a time for investors to buy and sell stocks and clean up portfolios. Some investors allocate excess cash to new investments or add to existing holdings. Hence, we discuss 5 stocking stuffer stocks for Christmas 2022. It makes sense to look at your portfolio and add to undervalued stocks with the prospect of solid total returns. Alternatively, some stocks that were overvalued for years are now more reasonably priced. As Peter Lynch says,

“My system for over 30 years has been this: When stocks are attractive, you buy them. Sure, they can go lower. I’ve bought stocks at $12 that went to $2, but then they later went to $30.”

We emphasize dividend stocks providing a list of five stocking stuffer stocks to consider for Christmas 2022. Some are undervalued because of recession fears, and others face company-specific issues. But they are attractively priced with dividend yields greater than the S&P 500 Index and solid dividend safety.

stocking stuffer stocks
5 Stocking Stuffer Stocks for Christmas 2022


The Sure Dividend Newsletter for high-quality dividend growth stocks.

  • The monthly newsletter includes stock analyses, portfolio ideas, dividend risk scores, real money portfolio, etc.
  • Risk free 7-day free trial and $41 off only through Dividend Power for $158 per year.
  • Sure Dividend Coupon Code – DP41S

Click here to try the Sure Dividend Newsletter (7-day free trial).

5 Stocking Stuffer Stocks for Christmas 2022

Verizon Communications

Verizon Communications (VZ) is a company we have talked about a few times this year. The telecommunications firm is struggling to grow its retail cellular subscribers. In response, investors have sold the stock. As a result, Verizon is down almost 29% in 2022. That said, Verizon is appreciably undervalued, trading at an earnings multiple of only 7.3X, nearly the lowest in the past decade.

Verizon’s dividend yield is nearly 7%, making it one of the highest-yielding blue-chip stocks and popular with dividend ETFs. The combination of low valuation compared to historical metrics and the high yield make the stock attractive for long-term investors. The excellent yield is combined with acceptable dividend safety of a ~47% payout ratio.

Verizon’s retail cellular growth should turn positive again as it rolls out faster 5G service across the country. As a result, investors will probably recognize the strong reward-to-risk profile in the future. Also, the stock is suitable for those seeking income with slow dividend growth.

Related Articles About Verizon on Dividend Power

Portfolio Insight - Dividend Yield History VZ
Source: Portfolio Insight*


The second stock on our list is Medtronic (MDT), the world’s largest medical device and consumables company. The firm faces company-specific issues related to its pipeline, FDA warning letter, inflationary pressures, and lower guidance. Shareholders have exited the stock, pushing the valuation below the long-term range and presenting an opportunity.

Medtronic’s dividend yield is about 3.4%, near its high in the past ten years, and backed by a reasonable payout ratio of ~56%. The Dividend Aristocrat is known for its 45 years of annual dividend increases. The dividend increases are about 8% annually now.

The company is on sale now and should overcome its challenges. Moreover, the firm is exiting the difficult Patient Monitoring and Respiratory Intervention business. The dividend yield, low valuation, and minimal investor outlook make Medtronic an excellent stock to look at now.

Related Articles About Medtronic on Dividend Power

Portfolio Insight - Dividend Yield History MDT
Source: Portfolio Insight*

Enterprise Products

Enterprise Products (EPD) is the only master limited partnership (MLP) on the list. The American pipeline company owns about 50,000+ miles of pipelines for natural gas, oil, refined products, and petrochemicals. The company has a storage capacity of about 260+ million barrels of oil and refined products and 14 billion cubic feet of natural gas.

The partnership’s unit prices are still trading below pre-pandemic levels, and the valuation is lower than the historical norm. Consequently, the dividend yield is elevated at nearly 8%. Investors expect little from EPD because of regulatory pressures and the expected transition to renewables. But the company has several projects coming to fruition, and demand for liquefied petroleum gas (LPG) and liquefied natural gas (LNG), is high.

The combination of undervaluation, high dividend yield, and potential future growth make the pipeline firm attractive now because of the prospect of a high dividend yield and growing future cash flows.

Related Articles About Enterprise Products Partners on Dividend Power

EPD Dividend Schedule
Source: Portfolio Insight*


Pfizer has benefitted immensely from the COVID-19 pandemic. The company’s sales increased dramatically with the COVID-19 vaccine, Cominranty, and the anti-viral drug, Plaxlovid. As a result, total revenue was $99,878 million in the past twelve months compared to $41,651 million in 2020. However, the market fears COVID-related revenue will decline in the future; hence, the stock price is still down in 2022.

That said, Pfizer has several drugs with $1+ billion in annual revenue, including the Prevnar vaccine, Ibrance, Elquis, Xtandi, Vyndaqel/Vyndamax, Xeljanz, and Enbrel. Hence, it is not wholly dependent on COVID-related therapies for future growth.

Furthermore, the firm has spent its cash wisely, acquiring companies and therapies and positioning it for growth. Since 2021, Pfizer has purchased Trillium for its cancer drug candidates, Arena for its autoimmune candidate, ReViral for its RSV programs, biohaven for its CGRP assets (migraines), and GBT for its sickle cell disease treatments.

Pfizer is a Dividend Contender with 13 years of annual increases. The forward dividend yield of about 3% is supported by a conservative payout ratio of 35.3% and stellar free cash flow, providing confidence about future growth and dividend safety.

The stock price has recovered slightly, but the forward P/E ratio is still only 8.4X, below the historical average. The low valuation and nice dividend yield make Pfizer a preferred choice of dividend exchange-traded funds, like VYM or SCHD. Small investors should probably follow their lead with this innovative company.

Related Articles About Pfizer on Dividend Power

Portfolio Insight - Revenue PFE
Source: Portfolio Insight*

Lowe’s Companies

Lowe’s Companies (LOW) is well-known to many small investors as one of North America’s two largest home improvement retailers. Like many retailers, the year 2022 has proven challenging. Rising mortgage rates typically cause new home construction to decline affecting sales. Also, high inflation is causing house owners to concentrate on necessities rather than home remodeling.

But Lowe’s is a company that investors should like for the long-term. The company grows by selling more items through its stores. It adds to the store count each year too. Years of growth have permitted the firm to return cash to shareholders. As a result, Lowe’s is a Dividend King and Dividend Aristocrat with 61 years of consecutive annual increases. The retailer has had a double-digit dividend growth rate in the past decade. In addition, the conservative payout ratio of around 23% allows many more dividend increases. 

Lowe’s stock price is down roughly 17% in 2022 and is an excellent opportunity. The forward price-to-earnings (P/E) ratio is ~15.3X below the historical range. The low valuation and high dividend growth rate make Lowe’s attractive now.

Related Articles About Lowe’s on Dividend Power

Portfolio Insight - Dividend Growth LOW
Source: Portfolio Insight*

Disclosure: Long VZ, MDT

A version of this post by Dividend Power originally appeared in Investor Place and was republished with permission.

Related Articles on Dividend Power

Here are my recommendations:


  • Simply Investing Report & Analysis Platform or the Course can teach you how to invest in stocks. Try it free for 14 days. 
  • Sure Dividend Newsletter is an excellent resource for DIY dividend growth investors and retirees. Try it free for 7 days.
  • Stock Rover is the leading investment research platform with all the fundamental metrics, screens, and analysis tools you need. Try it free for 14 days.
  • Portfolio Insight is the newest and most complete portfolio management tool with built-in stock screeners. Try it free for 14 days.

Receive a free e-book, “Become a Better Investor: 5 Fundamental Metrics to Know!” Join thousands of other readers !

*This post contains affiliate links meaning that I earn a commission for any purchases that you make at the Affiliates website through these links. This will not incur additional costs for you. Please read my disclosure for more information.

Website | + posts

Prakash Kolli is the founder of the Dividend Power site. He is a self-taught investor, analyst, and writer on dividend growth stocks and financial independence. His writings can be found on Seeking Alpha, InvestorPlace, Business Insider, Nasdaq, TalkMarkets, ValueWalk, The Money Show, Forbes, Yahoo Finance, and leading financial sites. In addition, he is part of the Portfolio Insight and Sure Dividend teams. He was recently in the top 1.0% and 100 (73 out of over 13,450) financial bloggers, as tracked by TipRanks (an independent analyst tracking site) for his articles on Seeking Alpha.

Leave a Reply

Your email address will not be published. Required fields are marked *